Dr. Joerg Moeller

Chief Executive Officer

Appointment to the Board
January 2024.

Experience and expertise
Before joining BenevolentAI, Dr. Moeller served as EVP, Head of Global Research and
Development and Member of the Global Leadership Team of LEO Pharma. He re-
organised and re-structured the global RD organisation to support growth and
innovation ambitions of the company.

Prior to LEO Pharma, Joerg was at Bayer AG where he held various executive roles
culminating in his appointment as EVP, Head of Pharmaceuticals Research and
Development and Member of the Executive Committee of the Pharmaceuticals Division
of Bayer AG. During his time at Bayer he successfully managed development and global
product approvals, redefined Bayer’s pipeline strategy and initiated several drug discovery
collaborations with AI platform companies and is a strong advocate of this strategy.
Joerg graduated as a Doctor of Medicine and holds a PhD from Ruhr University Bochum,

Current external appointments
Joerg currently serves on the Board of Secura Bio, a privately-held US biotech company.